We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 30, 2021

Nivolumab Alone or Combined With Ipilimumab in Patients With Advanced GIST

Clinical Cancer Research


Additional Info

Clinical Cancer Research
A Randomized Phase 2 Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Patients With Advanced Gastrointestinal Stromal Tumors
Clin. Cancer Res 2021 Aug 18;[EPub Ahead of Print], AS Singh, JR Hecht, L Rosen, ZA Wainberg, X Wang, M Douek, A Hagopian, R Andes, L Sauer, SR Brackert, W Chow, R DeMatteo, FC Eilber, JA Glaspy, B Chmielowski

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading